Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms

Схожие документы

• Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination
  по: Vrtala, Susanne, et al.
  Опубликовано: (2011)
• Bet v 1-specific IgE levels and PR-10 reactivity discriminate silent sensitization from phenotypes of birch allergy
  по: Elisyutina, Olga, et al.
  Опубликовано: (2019)
• NMR resonance assignments of a hypoallergenic isoform of the major birch pollen allergen Bet v 1
  по: Ahammer, Linda, et al.
  Опубликовано: (2017)
• Determination of IgE and IgG reactivity to more than 170 allergen molecules in paper-dried blood spots
  по: Garib, Victoria, et al.
  Опубликовано: (2018)
• Isolation of a high‐affinity Bet v 1‐specific IgG‐derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments
  по: Gadermaier, E., et al.
  Опубликовано: (2018)